RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 33 filers reported holding RENEO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,832,320 | -30.5% | 2,073,957 | 0.0% | 1.57% | -33.8% |
| Q3 2022 | $6,948,000 | +28.4% | 2,073,957 | 0.0% | 2.38% | +37.1% |
| Q2 2022 | $5,413,000 | -10.9% | 2,073,957 | 0.0% | 1.73% | +0.5% |
| Q1 2022 | $6,077,000 | -65.7% | 2,073,957 | 0.0% | 1.72% | -59.9% |
| Q4 2021 | $17,732,000 | +15.8% | 2,073,957 | 0.0% | 4.30% | +23.7% |
| Q3 2021 | $15,306,000 | -15.9% | 2,073,957 | +5.7% | 3.47% | -38.2% |
| Q2 2021 | $18,190,000 | – | 1,962,221 | – | 5.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |